On day @ ( week @ ) @ % ( @/@ ) of brodalumab subjects and @ % ( @/@ ) of placebo subjects achieved ACR@ ; @ % ( @/@ ) brodalumab subjects and @ % ( @/@ ) of placebo subjects achieved ACR@ ; and @ % ( @/@ ) brodalumab subjects and @ % ( @/@ ) of placebo subjects achieved ACR@ .